This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Christopher Hadfield: Innovator in Insulin Preparation
Introduction
Christopher Hadfield is a notable inventor based in Leicester, GB. He has made significant contributions to the field of biotechnology, particularly in the preparation of insulin. His innovative approach has the potential to enhance the efficiency of insulin production, which is crucial for diabetes management.
Latest Patents
Hadfield holds a patent titled "Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin A and B chains." This invention provides a protein precursor of a double-chain molecule that consists of at least two polypeptide chains linked by two disulfide bonds. The precursor has the general formula B—Z—A, where B and A represent the two insulin polypeptide chains, and Z is a polypeptide that includes at least one site for proteolytic cleavage. This method allows for the production of a secreted double-chain product consisting of the disulfide-bonded A and B chains, facilitating the isolation of mature insulin.
Career Highlights
Throughout his career, Hadfield has focused on advancing biotechnological methods for insulin production. His work has been instrumental in developing more effective ways to produce insulin, which is vital for individuals with diabetes. His innovative methods have the potential to streamline the production process and improve the quality of insulin available for medical use.
Collaborations
Hadfield has collaborated with notable professionals in his field, including Patnam Rajagopaliengar Krishnaswamy and Kaithamana Shashi. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Christopher Hadfield's contributions to insulin preparation through his innovative patent demonstrate his commitment to improving healthcare solutions. His work not only enhances the efficiency of insulin production but also has the potential to impact the lives of many individuals living with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile